Invention Grant
- Patent Title: 5-HT4 receptor antagonists for the treatment of heart failure
- Patent Title (中): 5-HT4受体拮抗剂用于治疗心力衰竭
-
Application No.: US12372592Application Date: 2009-02-17
-
Publication No.: US08829028B2Publication Date: 2014-09-09
- Inventor: Finn Olav Levy
- Applicant: Finn Olav Levy
- Applicant Address: NO Oslo
- Assignee: Serodus AS
- Current Assignee: Serodus AS
- Current Assignee Address: NO Oslo
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: GB0211230.8 20020516
- Main IPC: A61K31/436
- IPC: A61K31/436 ; A61K31/445 ; A61K31/453 ; A61K39/395 ; C07D405/02 ; A61K31/5365 ; A61K31/454 ; C07D405/12

Abstract:
This invention provides the use of a 5-HT4 receptor antagonist in the manufacture of a medicament for treating or preventing heart failure. Particular heart disorders to be treated are selected from the group comprising chronic heart failure, congestive heart failure, chronic congestive heart failure and heart failure resulting from ischaemic heart disease. Methods of treating heart failure using 5-HT4 receptor antagonists and pharmaceutical compositions containing 5-HT4 receptor antagonists are also provided.
Public/Granted literature
- US20090169545A1 5-HT4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF HEART FAILURE Public/Granted day:2009-07-02
Information query
IPC分类: